Vλ | Vκ | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Tissue | No. Clones | P | N | Mean | Mean CDR3 | No. Clones | P | N | Mean | Mean CDR3 |
Sample | Analyzed | Addition | Addition | No. N’s* | Length | Analyzed | Addition | Addition | No. N’s | Length |
AS Syn | 30 | 13.3% | 50.0% | 3.3 ± 6.1 | 10.5 ± 1.4 | 11 | 27.2.% | 54.5% | 1.7 ± 1.2 | 9.8±1.0 |
AS PBL | 20 | 30.0% | 45.0% | 2.4 ± 1.1 | 10.7 ±1.3 | 10 | 20.0% | 60.0% | 1.7 ± 1.2 | 9.9 ± 0.9 |
BC Syn | 21 | 33.3% | 42.8% | 1.9 ± 1.1 | 10.5 ± 1.1 | 14 | 35.7% | 57.1% | 1.8 ± 1.0 | 9.5 ± 1.2 |
BC PBL | 20 | 10.0% | 40.0% | 3.0 ± 1.3 | 10.3 ± 1.0 | 15 | 33.3% | 60.0% | 1.9 ± 2.3 | 9.3 ± 1.0 |
LB PBL | 18 | 16.7% | 33.3% | 2.5 ± 1.4 | 9.9 ± 1.1 | 12 | 25.0% | 16.7% | 3.0 ± 2.8 | 9.1 ± 0.5 |
LK PBL | 19 | 15.8% | 26.3% | 2.6 ± 1.3 | 9.7 ± 1.6 | 11 | 18.1% | 45.5% | 3.8 ± 4.1 | 9.5 ±0.7 |
IT PBL | 28 | 32.1% | 42.9% | 2.2 ± 1.6 | 10.4 ± 1.1 | 11 | 18.1% | 18.1% | 2.0 ± 1.4 | 9.0 ± 0.6 |